Biobehavioral intervention for Latino/Hispanic young adults with cancer
Official title: A Biobehavioral Intervention for Latino/Hispanic Young Adults with Cancer
Run by University of California, Irvine · NCT06338475 · Data updated 2026-11-12
This study is testing two different types of therapy to see which one helps Latino/Hispanic young adults who have survived cancer feel better and manage stress.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 39 Years |
| Sex | Men only |
| Enrollment | 100 (estimated) |
| Sponsor | University of California, Irvine Academic / other |
| Locations | 1 site (Irvine, California) |
| Status | Recruiting |
| Started | June 1, 2024 |
| Main results expected | June 2026 |
| Study ends | June 2026 |
| Registry record updated | March 25, 2025 |
| Trial ID | NCT06338475 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Hispanic/Latino males aged 18-39 who have been diagnosed with cancer between the ages of 15 and 39 and are experiencing distress.
✕Probably not a fit
Patients with a history of severe mental health disorders or cognitive impairments may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial evaluates the effectiveness of Goal-focused Emotion-Regulation Therapy (GET) compared to Instrumental Supportive Listening (ISL) in Latino/Hispanic young adult cancer survivors aged 18-39. Participants will undergo six sessions of either intervention over eight weeks, with assessments of psychological outcomes and stress-sensitive biomarkers at multiple time points. The study aims to address the unique challenges faced by this population, including high levels of distress and difficulties in goal navigation following cancer treatment.
Why it matters
Potential benefit: If successful, this intervention could significantly improve emotional regulation and overall well-being for young Latino/Hispanic cancer survivors.
How similar studies have gone: While this approach is tailored to a specific demographic, similar interventions have shown promise in improving psychological outcomes in cancer survivors.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 to 39 years at time of consent * Male gender; self-identified * A confirmed diagnosis of cancer (any stage) * Diagnosed with cancer between the ages of 15 and 39 * Hispanic/Latino identification * A score ≤ 1.8 on the Goal Navigation Scale or ≥ 4 on the Distress Thermometer * English or Spanish fluency Exclusion Criteria: * lifetime history of bipolar disorder, schizophrenia, schizoaffective disorder (self-report) * compromised cognitive capacity * self-reported medical condition or medication use known to confound measures of systemic inflammation (e.g., autoimmune disorder, active infection)
Where it's running
-
University of California, Irvine
Irvine, California, United States Recruiting
Study contacts
- Principal investigator: Michael A Hoyt, PhD — University of California, Irvine
- Study coordinator: Michael A Hoyt, PhD
- Email: mahoyt@uci.edu
- Phone: 949-824-5281
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.